comparemela.com

Latest Breaking News On - புற்றுநோய் ஆஸ்திரேலியா - Page 4 : comparemela.com

Promoting Cancer Screenings to Improve Early Detection Rates

Desperately disappointing setback for ovarian cancer screening hopes

‘Desperately disappointing’ setback for ovarian cancer screening hopes We’re sorry, this service is currently unavailable. Please try again later. Dismiss Save Normal text size Advertisement Long-awaited results of a major ovarian cancer study three decades in the making found screening women detected the disease before they developed symptoms but didn’t save lives. The findings are a devastating blow for ovarian cancer researchers, patients and their supporters who had hoped the trial involving more than 200,000 women would lead to early diagnosis and ultimately national screening programs that would prevent thousands of ovarian cancer deaths every year. Christy Smith was diagnosed with ovarian cancer in February 2020.

Roche leads industry sponsored oncology trials in Australia, says GlobalData

Search jobs Roche leads industry sponsored oncology trials in Australia, says GlobalData Australia has the highest age-standardized incidence rate for all cancers in the world and one of the countries with substantial cancer screening programs. Against this backdrop, several pharma companies are conducting clinical trials related to cancer drugs in the country. Among these, Roche continues to be a key player with the highest number of clinical trials in oncology indications, says GlobalData, a leading data and analytics company.   Ms. Sasmitha Sahu, Pharma Analyst at GlobalData, comments: “Despite high incidence rates, mortality rate is low in Australia due to early and extensive screening. Owing to the government’s greater focus on managing cancer, patients can gain access to good diagnostic facilities, healthcare and novel cancer therapies. Participation in clinical trials ensures early access to unapproved novel therapies.”  

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.